...
首页> 外文期刊>Cancer Cell >Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
【24h】

Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread

机译:卵巢癌的血源性转移:重新思考蔓延模式

获取原文
获取原文并翻译 | 示例
           

摘要

Ovarian cancer has a clear predilection for metastasis to the omentum, but the underlying mechanisms involved in ovarian cancer spread are not well understood. Here, we used a parabiosis model that demonstrates preferential hematogenous metastasis of ovarian cancer to the omentum. Our studies revealed that the ErbB3-neuregulin 1 (NRG1) axis is a dominant pathway responsible for hematogenous omental metastasis. Elevated levels of ErbB3 in ovarian cancer cells and NRG1 in the omentum allowed for tumor cell localization and growth in the omentum. Depletion of ErbB3 in ovarian cancer impaired omental metastasis. Our results highlight hematogenous metastasis as an important mode of ovarian cancer metastasis. These findings have implications for designing alternative strategies aimed at preventing and treating ovarian cancer metastasis.
机译:卵巢癌对Omentum的转移有明显的偏好,但涉及卵巢癌症蔓延的潜在机制并不能理解。 在这里,我们使用了一种曲静脉化模型,证明了对全膜的卵巢癌的优先血酸转移。 我们的研究表明,ERBB3-Neuregulin 1(NRG1)轴是负责血管题转移的主要途径。 卵巢癌细胞中的ErbB3水平升高,OENENTUM中的NRG1允许肿瘤细胞定位和整体生长。 卵巢癌患者的ERBB3损失伤害题为转移。 我们的结果突出了血液源性转移作为卵巢癌转移的重要模式。 这些调查结果对设计旨在预防和治疗卵巢癌转移的替代策略具有含义。

著录项

  • 来源
    《Cancer Cell》 |2014年第1期|共15页
  • 作者单位

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Cancer Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Systems Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Thoracic Head and Neck Medical Oncology University of Texas M.D. Anderson Cancer;

    Department of Cancer Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Biocept Inc. San Diego CA 92121 United States;

    Biocept Inc. San Diego CA 92121 United States;

    Department of Cancer Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Surgical Oncology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Experimental Therapeutics University of Texas M.D. Anderson Cancer Center Houston;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Cancer Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Cancer Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Benign Hematology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Systems Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Systems Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Pathology University of Texas M.D. Anderson Cancer Center Houston TX 77030 United;

    Department of Systems Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

    Department of Systems Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Experimental Therapeutics University of Texas M.D. Anderson Cancer Center Houston;

    Department of Cancer Biology University of Texas M.D. Anderson Cancer Center Houston TX 77030;

    Department of Gynecologic Oncology and Reproductive Medicine University of Texas M.D. Anderson;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号